Patent ID: 9518988
Filing Date: 2016-12-13
CPC Classification: A61K,A61P,C07K,G01N

Claim Text:
1. A method of alleviating the progression of an ErbB-family expressing cancer in a subject in need thereof, the method comprising: (a) administering a therapeutically effective amount of a first antibody or fragment thereof having the complementarity-determining regions (CDRs) of the monocloncal antibody deposit number CNCM I-4292 (Clone No. 551.6.103), deposited at the Collection Nationale De Cultures De Microorganismes (CNCM); and (b) administering a therapeutically effective amount of a second antibody or fragment thereof having the CDRs of the monoclonal antibody deposit number CNCM I-4291 (Clone No. 898.47), deposited at CNCM, thereby alleviating the progression of an ErbB-family expressing cancer in said subject.